{"id":"https://openalex.org/W2007997046","doi":"https://doi.org/10.1056/nejmoa071841","title":"Rofecoxib and Cardiovascular Adverse Events in Adjuvant Treatment of Colorectal Cancer","display_name":"Rofecoxib and Cardiovascular Adverse Events in Adjuvant Treatment of Colorectal Cancer","alternate_titles":[],"publication_year":2007,"publication_date":"2007-07-25","ids":{"openalex":"https://openalex.org/W2007997046","doi":"https://doi.org/10.1056/nejmoa071841","mag":"2007997046","pmid":"https://pubmed.ncbi.nlm.nih.gov/17652651"},"language":"en","primary_location":{"id":"doi:10.1056/nejmoa071841","doi":"https://doi.org/10.1056/nejmoa071841","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmoa071841","pdf_url":"http://wrap.warwick.ac.uk/94/1/WRAP_Dunn_360.pdf","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2007997046"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://wrap.warwick.ac.uk/94/1/WRAP_Dunn_360.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108056940","display_name":"David J. Kerr","orcid":"https://orcid.org/0009-0002-4486-8461","observed_orcids":["https://orcid.org/0009-0002-4486-8461"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David J. Kerr","raw_affiliation_strings":["Oncology Clinical Trials Office, University of Oxford, Oxford, United Kingdom. david.kerr@clinpharm.ox.ac.uk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Clinical Trials Office, University of Oxford, Oxford, United Kingdom. david.kerr@clinpharm.ox.ac.uk","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028914408","display_name":"Janet Dunn","orcid":"https://orcid.org/0000-0001-7313-4446","observed_orcids":["https://orcid.org/0000-0001-7313-4446"]},"institutions":[{"id":"https://openalex.org/I39555362","display_name":"University of Warwick","ror":"https://ror.org/01a77tt86","country_code":"GB","type":"education","lineage":["https://openalex.org/I39555362"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Janet A. Dunn","raw_affiliation_strings":["Statistical Centre at Warwick Medical School Clinical Trials Unit, University of Warwick, Coventry"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistical Centre at Warwick Medical School Clinical Trials Unit, University of Warwick, Coventry","institution_ids":["https://openalex.org/I39555362"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062679128","display_name":"Michael J. S. Langman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39555362","display_name":"University of Warwick","ror":"https://ror.org/01a77tt86","country_code":"GB","type":"education","lineage":["https://openalex.org/I39555362"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael J. Langman","raw_affiliation_strings":["Statistical Centre at Warwick Medical School Clinical Trials Unit, University of Warwick, Coventry"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistical Centre at Warwick Medical School Clinical Trials Unit, University of Warwick, Coventry","institution_ids":["https://openalex.org/I39555362"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111869956","display_name":"Justine L. Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Justine L. Smith","raw_affiliation_strings":["Oncology Clinical Trials Office, University of Oxford, Oxford"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Clinical Trials Office, University of Oxford, Oxford","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108092635","display_name":"Rachel S. Midgley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rachel S.J. Midgley","raw_affiliation_strings":["Oncology Clinical Trials Office, University of Oxford, Oxford"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Clinical Trials Office, University of Oxford, Oxford","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Andrew Stanley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799802789","display_name":"Birmingham City Hospital","ror":"https://ror.org/02smq5q54","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799630439","https://openalex.org/I2799802789"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrew Stanley","raw_affiliation_strings":["City Hospital, Birmingham"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City Hospital, Birmingham","institution_ids":["https://openalex.org/I2799802789"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108422768","display_name":"Joanne C. Stokes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joanne C. Stokes","raw_affiliation_strings":["Oncology Clinical Trials Office, University of Oxford, Oxford"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Clinical Trials Office, University of Oxford, Oxford","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041416682","display_name":"Patrick Julier","orcid":"https://orcid.org/0000-0002-5068-6894","observed_orcids":["https://orcid.org/0000-0002-5068-6894"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patrick Julier","raw_affiliation_strings":["Oncology Clinical Trials Office, University of Oxford, Oxford"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Clinical Trials Office, University of Oxford, Oxford","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000481919","display_name":"Claire Iveson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Claire Iveson","raw_affiliation_strings":["Oncology Clinical Trials Office, University of Oxford, Oxford"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Clinical Trials Office, University of Oxford, Oxford","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055968479","display_name":"Ravi Duvvuri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ravi Duvvuri","raw_affiliation_strings":["Oncology Clinical Trials Office, University of Oxford, Oxford"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Clinical Trials Office, University of Oxford, Oxford","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109002687","display_name":"Christopher C. McConkey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39555362","display_name":"University of Warwick","ror":"https://ror.org/01a77tt86","country_code":"GB","type":"education","lineage":["https://openalex.org/I39555362"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christopher C. McConkey","raw_affiliation_strings":["Statistical Centre at Warwick Medical School Clinical Trials Unit, University of Warwick, Coventry"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Statistical Centre at Warwick Medical School Clinical Trials Unit, University of Warwick, Coventry","institution_ids":["https://openalex.org/I39555362"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":11.7534,"has_fulltext":true,"cited_by_count":146,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.99041253,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"357","issue":"4","first_page":"360","last_page":"369"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rofecoxib","display_name":"rofecoxib","score":1.0},{"id":"https://openalex.org/keywords/adverse-cardiovascular-events","display_name":"cardiovascular adverse events","score":0.8550000190734863},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.921999990940094},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.9390000104904175},{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.671999990940094},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.8429999947547913},{"id":"https://openalex.org/keywords/stroke","display_name":"stroke","score":0.8119999766349792},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4020000100135803},{"id":"https://openalex.org/keywords/trial-termination","display_name":"trial termination","score":0.3449999988079071},{"id":"https://openalex.org/keywords/recurrence-prevention","display_name":"recurrence prevention","score":0.4129999876022339},{"id":"https://openalex.org/keywords/stage-ii-iii-colorectal-cancer","display_name":"stage II and III colorectal cancer","score":0.7350000143051147}],"concepts":[{"id":"https://openalex.org/C2778582115","wikidata":"https://www.wikidata.org/wiki/Q411412","display_name":"Rofecoxib","level":4,"score":0.9776898622512817},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9750199317932129},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6754604578018188},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.660483181476593},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.6275705695152283},{"id":"https://openalex.org/C119060515","wikidata":"https://www.wikidata.org/wiki/Q1916617","display_name":"Interquartile range","level":2,"score":0.5912466645240784},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5331916809082031},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.5008924007415771},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.4959741532802582},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.4531521797180176},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4266829490661621},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.38323548436164856},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.2865679860115051},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.1200326681137085},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0689246654510498},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000236","descriptor_name":"Adenoma","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D000236","descriptor_name":"Adenoma","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D012306","descriptor_name":"Risk","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013450","descriptor_name":"Sulfones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D013450","descriptor_name":"Sulfones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1056/nejmoa071841","doi":"https://doi.org/10.1056/nejmoa071841","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmoa071841","pdf_url":"http://wrap.warwick.ac.uk/94/1/WRAP_Dunn_360.pdf","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},{"id":"pmid:17652651","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17652651","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Journal Article"},{"id":"pmh:oai:wrap.warwick.ac.uk:94","doi":null,"is_oa":false,"landing_page_url":"http://wrap.warwick.ac.uk/94/1/WRAP_Dunn_360.pdf","pdf_url":"http://wrap.warwick.ac.uk/94/1/WRAP_Dunn_360.pdf","source":{"id":"https://openalex.org/S4306400665","display_name":"Warwick Research Archive Portal (University of Warwick)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I39555362","host_organization_name":"University of Warwick","host_organization_lineage":["https://openalex.org/I39555362"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1056/nejmoa071841","doi":"https://doi.org/10.1056/nejmoa071841","is_oa":true,"landing_page_url":"https://doi.org/10.1056/nejmoa071841","pdf_url":"http://wrap.warwick.ac.uk/94/1/WRAP_Dunn_360.pdf","source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306155","display_name":"Cancer Research Institute","ror":"https://ror.org/02f3xk561"},{"id":"https://openalex.org/F4320310702","display_name":"National Cancer Research Institute","ror":"https://ror.org/02mp0vf47"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2007997046.pdf","grobid_xml":"https://content.openalex.org/works/W2007997046.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W1480887469","https://openalex.org/W1973378060","https://openalex.org/W1976739913","https://openalex.org/W2011560877","https://openalex.org/W2012920835","https://openalex.org/W2018501386","https://openalex.org/W2042042913","https://openalex.org/W2044750065","https://openalex.org/W2051279880","https://openalex.org/W2063252400","https://openalex.org/W2067621583","https://openalex.org/W2077991158","https://openalex.org/W2081761148","https://openalex.org/W2100631748","https://openalex.org/W2148327508","https://openalex.org/W2158131645","https://openalex.org/W2158968701","https://openalex.org/W2172116130","https://openalex.org/W2225065195","https://openalex.org/W2243839336","https://openalex.org/W4239471829"],"related_works":["https://openalex.org/W2158131645","https://openalex.org/W4245096100","https://openalex.org/W2117955827","https://openalex.org/W2471371472","https://openalex.org/W2117784691","https://openalex.org/W2158968701","https://openalex.org/W2161123015","https://openalex.org/W2057497714","https://openalex.org/W2625634609","https://openalex.org/W2615945013"],"abstract_inverted_index":{"BACKGROUND:":[0],"Selective":[1],"cyclooxygenase":[2],"inhibitors":[3],"may":[4],"retard":[5],"the":[6,106,126,155,164,173,184,198,246,252,275,281,294,299,305,312],"progression":[7],"of":[8,29,31,62,88,114,139,181,197,207,215,220,231,264,328,339],"cancer,":[9],"but":[10],"they":[11],"have":[12],"enhanced":[13],"thrombotic":[14,42,98,159,242,286],"potential.":[15],"We":[16],"report":[17],"on":[18],"cardiovascular":[19,41,97,158,241,317,330],"adverse":[20,37,329],"events":[21,38,43,99,331],"in":[22,46,57,163,245,274,280,304,311],"patients":[23,48,122,128,273,310,333],"receiving":[24,123,129],"rofecoxib":[25,124,165,247,276,306],"to":[26,85,102,145,151,193,236,269],"reduce":[27],"rates":[28],"recurrence":[30],"colorectal":[32,54],"cancer.":[33],"METHODS:":[34],"All":[35],"serious":[36],"that":[39],"were":[40,44,131,249],"reviewed":[45],"2434":[47],"with":[49,134,176,258,324,334],"stage":[50],"II":[51],"or":[52,75,168,289],"III":[53],"cancer":[55],"participating":[56],"a":[58,135,335],"randomized,":[59],"placebo-controlled":[60],"trial":[61,80,107,256],"rofecoxib,":[63],"25":[64],"mg":[65],"daily,":[66],"started":[67],"after":[68,105,172,255,293],"potentially":[69],"curative":[70],"tumor":[71],"resection":[72],"and":[73,125,147,212,219,223,278,297,308],"chemotherapy":[74],"radiotherapy":[76],"as":[77],"indicated.":[78],"The":[79,111,120],"was":[81,108,117,322],"terminated":[82],"prematurely":[83],"owing":[84],"worldwide":[86],"withdrawal":[87],"rofecoxib.":[89],"To":[90],"examine":[91],"possible":[92],"persistent":[93],"risks,":[94],"we":[95],"examined":[96],"reported":[100,250],"up":[101],"24":[103],"months":[104,141,149],"closed.":[109],"RESULTS:":[110],"median":[112,136,336],"duration":[113],"active":[115],"treatment":[116,174,295,338],"7.4":[118,340],"months.":[119],"1167":[121],"1160":[127],"placebo":[130,282,313],"well":[132],"matched,":[133],"follow-up":[137,300],"period":[138],"33.0":[140],"(interquartile":[142],"range,":[143],"27.6":[144],"40.1)":[146],"33.4":[148],"(27.7":[150],"40.4),":[152],"respectively.":[153],"Of":[154],"23":[156],"confirmed":[157],"events,":[160,243],"16":[161],"occurred":[162],"group":[166,277,283,307,314],"during":[167,288,298],"within":[169,251,290],"14":[170,291],"days":[171,292],"period,":[175,296,301],"an":[177,227,259,325],"estimated":[178],"relative":[179,229,262],"risk":[180,230,263],"2.66":[182],"(from":[183],"Cox":[185],"proportional-hazards":[186],"model;":[187],"95%":[188],"confidence":[189],"interval":[190],"[CI],":[191],"1.03":[192],"6.86;":[194],"P=0.04).":[195],"Analysis":[196],"Antiplatelet":[199],"Trialists'":[200],"Collaboration":[201],"end":[202],"point":[203],"(the":[204],"combined":[205],"incidence":[206],"death":[208],"from":[209,285,316],"cardiovascular,":[210],"hemorrhagic,":[211],"unknown":[213],"causes;":[214],"nonfatal":[216,221],"myocardial":[217],"infarction;":[218],"ischemic":[222],"hemorrhagic":[224],"stroke)":[225],"gave":[226],"unadjusted":[228,261],"1.60":[232],"(95%":[233,266],"CI,":[234,267],"0.57":[235],"4.51;":[237],"P=0.37).":[238],"Fourteen":[239],"more":[240],"six":[244],"group,":[248],"2":[253],"years":[254],"closure,":[257],"overall":[260],"1.50":[265],"0.76":[268],"2.94;":[270],"P=0.24).":[271],"Four":[272],"two":[279],"died":[284,315],"causes":[287],"one":[302],"patient":[303],"five":[309],"causes.":[318],"CONCLUSIONS:":[319],"Rofecoxib":[320],"therapy":[321],"associated":[323],"increased":[326],"frequency":[327],"among":[332],"study":[337],"months'":[341],"duration.":[342],"(Current":[343],"Controlled":[344],"Trials":[345],"number,":[346],"ISRCTN98278138":[347],"[controlled-trials.com].).":[348]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2007997046","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":14}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
